|
Volumn 88, Issue 8, 2003, Pages 665-
|
Influenza vaccine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INACTIVATED VACCINE;
INFLUENZA VACCINE;
ASTHMA;
CHILD;
CHRONIC DISEASE;
DIABETES MELLITUS;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
HUMAN;
IMMUNE DEFICIENCY;
INFECTION PREVENTION;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS;
LUNG FUNCTION;
LUNG TOXICITY;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
CHILD;
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
PATIENT SELECTION;
PRACTICE GUIDELINES;
RISK ASSESSMENT;
|
EID: 0042768685
PISSN: 00039888
EISSN: 14682044
Source Type: Journal
DOI: 10.1136/adc.88.8.665 Document Type: Review |
Times cited : (2)
|
References (9)
|